FDA Flouted Law To Undercut $375K Drug, Suit Says
The U.S. Food and Drug Administration unlawfully approved a lower-cost version of a $375,000 per year drug for a rare autoimmune disease because of concerns about affordability, according to a lawsuit...To view the full article, register now.
Already a subscriber? Click here to view full article